CCR5 antagonists were in clinical development for other indications when it was identified that naturally occurring lack of CCR5, due to a homozygous deletion mutant, imparted marked resistance to HIV infection but did not adversely affect immune function [33]. Here, CCR5 is linked to HIV infectious disease.